14
Views
11
CrossRef citations to date
0
Altmetric
Review

Current treatment options for vulvovaginal atrophy

&
Pages 141-151 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Gregory T Wurz, Chiao-Jung Kao & Michael W DeGregorio. (2014) Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause. Clinical Interventions in Aging 9, pages 1939-1950.
Read now
Lin H Soe, Gregory T Wurz, Chiao-Jung Kao & Michael W DeGregorio. (2013) Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast. International Journal of Women's Health 5, pages 605-611.
Read now

Articles from other publishers (9)

Daniel María Lubián López. (2022) Management of genitourinary syndrome of menopause in breast cancer survivors: An update. World Journal of Clinical Oncology 13:2, pages 71-100.
Crossref
Ying Sheng, Janet Carpenter, Andrea Cohee, Susan Storey, Timothy Stump, Patrick Monahan, David Cella & Victoria Champion. (2021) Genitourinary Symptoms in Breast Cancer Survivors: Prevalence, Correlates, and Relationship With Sexual Functioning. Oncology Nursing Forum 48:2, pages 229-241.
Crossref
Rebeca Stahlschmidt, Amanda Canato Ferracini, Cinthia Madeira de Souza, Luana Moreira de Medeiros, Cassia Raquel Teatin Juliato & Priscila Gava Mazzola. (2019) Adherence and quality of life in women with breast cancer being treated with oral hormone therapy. Supportive Care in Cancer 27:10, pages 3799-3804.
Crossref
Mariana S. SousaMichelle Peate, Sherin Jarvis, Martha Hickey & Michael Friedlander. (2017) A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy. Therapeutic Advances in Medical Oncology 9:4, pages 269-285.
Crossref
Jae Jun ShinSeul Ki KimJung Ryeol LeeChang Suk Suh. (2017) Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy. Journal of Menopausal Medicine 23:2, pages 79.
Crossref
Shelley Elkinson & Lily P. H. Yang. (2013) Ospemifene: First Global Approval. Drugs 73:6, pages 605-612.
Crossref
Gregory T. Wurz, Lin H. Soe & Michael W. DeGregorio. (2013) Ospemifene, vulvovaginal atrophy, and breast cancer. Maturitas 74:3, pages 220-225.
Crossref
Sezer Kısa & Nurgül Özdemir. (2012) Vaginal Dryness Problems Among Southeastern Women Aged 40–65 Years in Turkey. Sexuality and Disability 31:1, pages 71-82.
Crossref
Shayne Cox GadGregory T. Wurz & Michael W. DeGregorio. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.